LMCG INVESTMENTS, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1470944 BOSTON, MA

Position in REGN

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$22,969,342

-$7,147,392 QoQ

Shares Held

36,837

-5.5% QoQ

Ownership

0.036%

of shares outstanding

% of Portfolio

1.45%

of 13F equity value

Holder Rank

#198

of 1,322 holders

Holding Since

Mar 2022

18 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

LMCG INVESTMENTS, LLC holds $22,969,342 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	REGN	Regeneron Pharmaceuticals, Inc. This page	36,837	$22,969,342

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$22,969,342	36,837	-5.5%	Shares	Sole	2026-07-22
2026-03-31	$30,116,734	38,979	-2.1%	Shares	Sole	2026-04-29
2025-12-31	$30,736,635	39,821	+9.8%	Shares	Sole	2026-02-03
2025-09-30	$20,390,721	36,265	+7.9%	Shares	Sole	2025-10-29
2025-06-30	$17,638,425	33,597	+132.0%	Shares	Sole	2025-07-24
2025-03-31	$9,184,284	14,481	+231.3%	Shares	Other	2025-04-10
2024-12-31	$3,113,594	4,371	-9.4%	Shares	Sole	2025-01-16
2024-09-30	$5,071,181	4,824	-0.2%	Shares	Sole	2024-10-29
2024-06-30	$5,078,576	4,832	+4.7%	Shares	Sole	2024-08-09
2024-03-31	$4,443,816	4,617	-0.3%	Shares	Sole	2024-05-06
2023-12-31	$4,068,239	4,632	-0.3%	Shares	Sole	2024-02-08
2023-09-30	$3,823,472	4,646	-2.3%	Shares	Sole	2023-11-03
2023-06-30	$3,417,376	4,756	-2.6%	Shares	Sole	2023-08-03
2023-03-31	$4,013,857	4,885	+1.5%	Shares	Sole	2023-05-05
2022-12-31	$3,473,974	4,815	+1.2%	Shares	Sole	2023-02-07
2022-09-30	$3,276,265	4,756	+1.0%	Shares	Sole	2022-11-08
2022-06-30	$2,783,040	4,708	+1.7%	Shares	Sole	2022-08-08
2022-03-31	$3,233,684	4,630	—	Shares	Sole	2022-05-10
No filing history on record for this holder in this stock.